125 related articles for article (PubMed ID: 11169925)
41. Peptide ligands in antibacterial drug discovery: use as inhibitors in target validation and target-based screening.
Lapan KA; Chapple JP; Galcheva-Gargova Z; Yang M; Tao J
Expert Opin Ther Targets; 2002 Aug; 6(4):507-16. PubMed ID: 12223065
[TBL] [Abstract][Full Text] [Related]
42. A surrogate-based approach for post-genomic partner identification.
Pillutla RC; Hsiao K; Brissette R; Eder PS; Giordano T; Fletcher PW; Lennick M; Blume AJ; Goldstein NI
BMC Biotechnol; 2001; 1():6. PubMed ID: 11602024
[TBL] [Abstract][Full Text] [Related]
43. Biochemical target isolation for novices: affinity-based strategies.
Sato S; Murata A; Shirakawa T; Uesugi M
Chem Biol; 2010 Jun; 17(6):616-23. PubMed ID: 20609411
[TBL] [Abstract][Full Text] [Related]
44. Discovery and design of peptide mimetics.
Moore GJ
Proc West Pharmacol Soc; 1997; 40():115-9. PubMed ID: 9436230
[No Abstract] [Full Text] [Related]
45. mRNA display: from basic principles to macrocycle drug discovery.
Josephson K; Ricardo A; Szostak JW
Drug Discov Today; 2014 Apr; 19(4):388-99. PubMed ID: 24157402
[TBL] [Abstract][Full Text] [Related]
46. Small-molecule affinity chromatography coupled mass spectrometry for drug target deconvolution.
Saxena C; Higgs RE; Zhen E; Hale JE
Expert Opin Drug Discov; 2009 Jul; 4(7):701-14. PubMed ID: 23489165
[TBL] [Abstract][Full Text] [Related]
47. Functional cell-based uHTS in chemical genomic drug discovery.
Croston GE
Trends Biotechnol; 2002 Mar; 20(3):110-5. PubMed ID: 11841862
[TBL] [Abstract][Full Text] [Related]
48. Disulfide-Directed Multicyclic Peptide Libraries for the Discovery of Peptide Ligands and Drugs.
Lu S; Fan S; Xiao S; Li J; Zhang S; Wu Y; Kong C; Zhuang J; Liu H; Zhao Y; Wu C
J Am Chem Soc; 2023 Jan; 145(3):1964-1972. PubMed ID: 36633218
[TBL] [Abstract][Full Text] [Related]
49. Drug target discovery using retroviruses.
Blø M; Micklem DR; Lorens JB
Expert Opin Drug Discov; 2007 Oct; 2(10):1285-300. PubMed ID: 23484527
[TBL] [Abstract][Full Text] [Related]
50. Advances in methods for therapeutic peptide discovery, design and development.
Pirogova E; Istivan T; Gan E; Cosic I
Curr Pharm Biotechnol; 2011 Aug; 12(8):1117-27. PubMed ID: 21470146
[TBL] [Abstract][Full Text] [Related]
51. From peptides to small molecules: an intriguing but intricated way to new drugs.
Scognamiglio PL; Di Natale C; Perretta G; Marasco D
Curr Med Chem; 2013; 20(31):3803-17. PubMed ID: 23895692
[TBL] [Abstract][Full Text] [Related]
52. From noncovalent to covalent bonds: a paradigm shift in target protein identification.
Park J; Koh M; Park SB
Mol Biosyst; 2013 Apr; 9(4):544-50. PubMed ID: 23354063
[TBL] [Abstract][Full Text] [Related]
53. Peptide display in functional genomics.
Fisch I
Comb Chem High Throughput Screen; 2001 Apr; 4(2):157-69. PubMed ID: 11281832
[TBL] [Abstract][Full Text] [Related]
54. Peptide aptamers: tools for biology and drug discovery.
Crawford M; Woodman R; Ko Ferrigno P
Brief Funct Genomic Proteomic; 2003 Apr; 2(1):72-9. PubMed ID: 15243998
[TBL] [Abstract][Full Text] [Related]
55. Towards High-Throughput Chemobehavioural Phenomics in Neuropsychiatric Drug Discovery.
Henry J; Wlodkowic D
Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31174272
[TBL] [Abstract][Full Text] [Related]
56. Identification of nonstandard macrocyclic peptide ligands through display screening.
Taylor RD; Rey-Carrizo M; Passioura T; Suga H
Drug Discov Today Technol; 2017 Dec; 26():17-23. PubMed ID: 29249238
[TBL] [Abstract][Full Text] [Related]
57. The future of post-genomic biology at the proteomic level: an outlook.
Crameri R; Schulz-Knappe P; Zucht HD
Comb Chem High Throughput Screen; 2005 Dec; 8(8):807-10. PubMed ID: 16464168
[TBL] [Abstract][Full Text] [Related]
58. Phage display for target-based antibacterial drug discovery.
Christensen DJ; Gottlin EB; Benson RE; Hamilton PT
Drug Discov Today; 2001 Jul; 6(14):721-727. PubMed ID: 11445463
[TBL] [Abstract][Full Text] [Related]
59. Small molecule complementarity as a source of novel pharmaceutical agents and combination therapies.
Root-Bernstein RS; Dillon PF
Curr Pharm Des; 2008; 14(1):55-62. PubMed ID: 18220818
[TBL] [Abstract][Full Text] [Related]
60. Harnessing the antioxidant power with ARE-inducing compounds.
Kobayashi M
Chem Biol; 2010 May; 17(5):419-20. PubMed ID: 20534340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
